Investigation of Normocytic Normochromic Anemia Found in Peripheral Smear
The most effective approach to investigating normocytic normochromic anemia is to first determine the underlying mechanism through reticulocyte count and then pursue targeted testing based on whether the anemia is due to decreased production or increased destruction/loss of red blood cells. 1
Initial Diagnostic Workup
Step 1: Confirm Anemia and Morphology
- Verify hemoglobin level (anemia defined as Hb <11 g/dL or a decrease of ≥2 g/dL from baseline) 1
- Confirm normocytic (MCV 80-100 fL) and normochromic characteristics on peripheral smear 1
- Carefully examine peripheral blood smear for subtle morphologic abnormalities 1
Step 2: Determine Mechanism - Kinetic Approach
- Measure reticulocyte count and calculate reticulocyte index (RI) - this is the critical branch point in the diagnostic algorithm 1
- Low RI (<1.0): Indicates decreased RBC production
- Normal/High RI (≥1.0-2.0): Indicates normal/increased production with blood loss or hemolysis
Diagnostic Pathway Based on Reticulocyte Index
For Low Reticulocyte Index (Decreased Production)
Iron studies:
- Serum iron, TIBC, transferrin saturation, ferritin
- Look for transferrin saturation <15% and ferritin <30 ng/mL (absolute iron deficiency) 1
- Note: Chronic inflammation may elevate ferritin despite iron deficiency
Renal function tests:
- BUN, creatinine to assess for anemia of chronic kidney disease 1
Inflammatory markers:
- ESR, CRP to evaluate for anemia of chronic inflammation/disease 1
Nutritional assessment:
- Vitamin B12 and folate levels (even though typically cause macrocytic anemia, early deficiency may present as normocytic) 1
Endocrine evaluation:
- TSH, free T4 to rule out hypothyroidism
- Consider testosterone levels in men
Bone marrow examination if other tests inconclusive:
- Aspirate and biopsy to assess for:
- Myelodysplastic syndrome
- Aplastic anemia
- Marrow infiltration (malignancy, fibrosis)
- Early megaloblastic changes 1
- Aspirate and biopsy to assess for:
For Normal/High Reticulocyte Index (Blood Loss or Hemolysis)
Blood loss evaluation:
- Occult blood testing (stool guaiac)
- Endoscopic evaluation if GI blood loss suspected
- Gynecologic evaluation in women with menorrhagia
Hemolysis workup:
- LDH, haptoglobin, unconjugated bilirubin
- Direct antiglobulin test (Coombs test) - especially important in patients with chronic lymphocytic leukemia, non-Hodgkin's lymphoma, or autoimmune disease 1
- Peripheral smear review for schistocytes or other RBC abnormalities
- Consider hemoglobinopathy evaluation if clinically indicated
Special Considerations
Cancer-Related Anemia
- Review medication history for myelosuppressive agents
- Consider bone marrow infiltration by malignancy
- Evaluate for functional iron deficiency in patients receiving ESAs 1
Elderly Patients
- Lower threshold for bone marrow examination in elderly patients with unexplained normocytic anemia
- Consider myelodysplastic syndrome even with normal peripheral smear 2
Chronic Disease Evaluation
- Thorough review of systems to identify underlying chronic conditions
- Consider occult infection, autoimmune disease, or malignancy 1
Common Pitfalls to Avoid
Missing early iron deficiency: Iron deficiency initially presents as normocytic before becoming microcytic - check iron studies even in normocytic anemia 1
Overlooking anemia of chronic disease: Often mistaken for iron deficiency - check ferritin and transferrin saturation to differentiate 3
Failing to perform peripheral smear review: Visual examination is critical and may reveal subtle abnormalities missed by automated analyzers 1
Premature bone marrow examination: In most cases of "idiopathic" normocytic anemia, bone marrow examination rarely changes management and should be reserved for cases where initial non-invasive testing is inconclusive 2
Not considering drug-induced anemia: Always take a thorough medication history as many drugs can cause normocytic anemia 3
By following this systematic approach, you can efficiently identify the underlying cause of normocytic normochromic anemia and direct appropriate treatment to address both the anemia and its root cause.